A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.
Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also reaped blockbuster sales for Gilead.
Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.
The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.
New data from the International Liver Congress in London this past weekend showed strong efficacy for Gilead's Sovaldi and AbbVie's combo regimen when paired with ribavirin.